Efficacy and safety of bevacizumab plus chemotherapy in chinese patients with metastatic colorectal cancer:A randomized phase iii artist trial | |
Guan Zhongzhen; Xu Jianming; Luo Rongcheng; Feng Fengyi; Wang Liwei; Shen Lin; Yu Shiying; Ba Yi; Liang Jun; Wang Dong | |
2011 | |
卷号 | 30期号:10页码:682-689 |
关键词 | Bevacizumab Chemotherapy First-line treatment Chinese patients Metastatic colorectal cancer |
URL标识 | 查看原文 |
收录类别 | CSCD |
内容类型 | 期刊论文 |
URI标识 | http://www.corc.org.cn/handle/1471x/6725556 |
专题 | 中国医学科学院 北京协和医学院 |
推荐引用方式 GB/T 7714 | Guan Zhongzhen,Xu Jianming,Luo Rongcheng,et al. Efficacy and safety of bevacizumab plus chemotherapy in chinese patients with metastatic colorectal cancer:A randomized phase iii artist trial[J],2011,30(10):682-689. |
APA | Guan Zhongzhen.,Xu Jianming.,Luo Rongcheng.,Feng Fengyi.,Wang Liwei.,...&Xu Ruihua.(2011).Efficacy and safety of bevacizumab plus chemotherapy in chinese patients with metastatic colorectal cancer:A randomized phase iii artist trial.,30(10),682-689. |
MLA | Guan Zhongzhen,et al."Efficacy and safety of bevacizumab plus chemotherapy in chinese patients with metastatic colorectal cancer:A randomized phase iii artist trial".30.10(2011):682-689. |
个性服务 |
查看访问统计 |
相关权益政策 |
暂无数据 |
收藏/分享 |
除非特别说明,本系统中所有内容都受版权保护,并保留所有权利。
修改评论